Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 5/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.52 |
| ▸ | PPARG | P37231 | 7/20 | 0.52 |
| ▸ | PPARD | Q03181 | 7/20 | 0.52 |
| ▸ | PPARA | Q07869 | 7/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4272551 | 0.97 | TSHR (0.63) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL22561248 | 0.97 | TSHR (0.63) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL15641446 | 0.97 | TSHR (0.63) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL6115837 | 0.97 | TSHR (0.63) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL10158623 | 0.97 | TSHR (0.63) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL4129515 | 0.97 | TSHR (0.63) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL1993165 | 0.94 | — | — | |
| Adipic Acid SCHEMBL2134438 | 0.88 | LMNA (0.69) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Adipic Acid SCHEMBL20956018 | 0.88 | LMNA (0.69) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL28675687 | 0.87 | SLC22A6 (0.52) | LMNATSHRNFKB1PMP22AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113224382-A | Solid polymer electrolyte containing ketone group and battery | 中国科学院大学 | 2021-08-06 | — | — | CN | claimed |
| US-12503543-B2 | Curable photochromic polycarbodiimide compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2025-12-23 | — | — | US | disclosed |
| US-12247168-B2 | Curable photochromic compositions including an oxazoline functional material | TRANSITIONS OPTICAL, LTD. (IE) | 2025-03-11 | — | — | US | disclosed |
| CN-114901717-B | Curable photochromic polymers carbodiimide composition | 光学转变有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-20230374230-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2023-11-23 | — | — | US | disclosed |
| CN-116761848-A | Crosslinked gel formulations | 依视路国际公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-113224382-B | Solid polymer electrolyte containing ketone group and battery | 中国科学院大学 | 2023-03-17 | — | — | CN | disclosed |
| US-20230059569-A1 | Curable Photochromic Compositions Including an Oxazoline Functional Material | TRANSITIONS OPTICAL, LTD. (IE) | 2023-02-23 | — | — | US | disclosed |
| US-20230054095-A1 | Curable Photochromic Polycarbodiimide Compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2023-02-23 | — | — | US | disclosed |
| EP-4081595-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING AN OXAZOLINE FUNCTIONAL MATERIAL | Transitions Optical, Ltd. (IE) | 2022-11-02 | — | — | EP | disclosed |
| US-20050267252-A1 | Electrophoretic particles and production process thereof | CANON KABUSHIKI KAISHA (JP) | 2005-12-01 | — | — | US | disclosed |
| US-20050227155-A1 | Electrophoretic particles, electrophoretic dispersion liquid, and electrophoretic display device | CANON KABUSHIKI KAISHA (JP) | 2005-10-13 | — | — | US | disclosed |
| CN-1220676-C | Method for producing acid anhydride | TOKUYAMA CORP (JP) | 2005-09-28 | — | — | CN | disclosed |
| WO-2005031451-A1 | ELECTROPHORETIC DISPERSION LIQUID AND ELECTROPHORETIC DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2005-04-07 | — | — | WO | disclosed |
| US-20040242929-A1 | Process for production of acid anhydride | TOKUYAMA CORPORATION (JP) | 2004-12-02 | — | — | US | disclosed |
| CN-1537097-A | Method for producing acid anhydride | ��ʽ�����ɽ | 2004-10-13 | — | — | CN | disclosed |
| EP-1413572-A1 | PROCESS FOR PRODUCING ACID ANHYDRIDE | Tokuyama Corporation (JP) | 2004-04-28 | — | — | EP | disclosed |
| US-4924015-A | PREPARING METALLIC COATINGS AND IMAGES | CIBA-GEIGY CORPORATION (US) | 1990-05-08 | — | — | US | disclosed |
| EP-0298034-A2 | Substituted anthraquinones and their use in epoxy resins | CIBA-GEIGY AG (CH) | 1989-01-04 | — | — | EP | disclosed |
| US-4113705-A | Triisocyanates useful for the production of polyurethane resins | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242929-A1 | Process for production of acid anhydride | CA4, CA9, CA6 | LMNA 3774/4885TSHR 565/4885NFKB1 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.